8-K Announcements
5May 5, 2026·SEC
Feb 3, 2026·SEC
Nov 5, 2025·SEC
Enact Holdings, Inc. (ACT) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Enact Holdings, Inc. (ACT) stock price & volume — 10-year historical chart
Enact Holdings, Inc. (ACT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Enact Holdings, Inc. (ACT) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 3, 2026 | $1.23vs $1.09+12.8% | $313Mvs $317M-1.4% |
| Q4 2025 | Nov 5, 2025 | $1.12vs $1.12+0.0% | $311Mvs $316M-1.3% |
| Q3 2025 | Jul 30, 2025 | $1.15vs $1.11+3.6% | $305Mvs $310M-1.8% |
| Q2 2025 | Apr 30, 2025 | $1.10vs $1.12-1.8% | $307Mvs $302M+1.5% |
Enact Holdings, Inc. (ACT) competitors in Mortgage and Title Insurance — business model, growth, and fundamentals comparison
Enact Holdings, Inc. (ACT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Enact Holdings, Inc. (ACT) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 841.1M | 978.85M | 1.11B | 1.12B | 1.09B | 1.15B | 1.2B | 1.23B |
| Revenue Growth % | - | 16.38% | 13.04% | 1.24% | -2.26% | 5.37% | 4.18% | 2.37% |
| Medical Costs & Claims | 0 | 260.68M | 615.8M | 371.63M | 145.13M | 250.31M | 261.63M | 109.53M |
| Medical Cost Ratio % | 0% | 26.63% | 55.65% | 33.18% | 13.25% | 21.7% | 21.77% | 8.9% |
| Gross Profit | 841.1M▲ 0% | 718.17M▼ 14.6% | 490.66M▼ 31.7% | 748.55M▲ 52.6% | 949.75M▲ 26.9% | 903.38M▼ 4.9% | 940.31M▲ 4.1% | 1.12B▲ 19.2% |
| Gross Margin % | 100% | 73.37% | 44.35% | 66.82% | 86.75% | 78.3% | 78.23% | 91.1% |
| Gross Profit Growth % | - | -14.62% | -31.68% | 52.56% | 26.88% | -4.88% | 4.09% | 19.2% |
| Operating Expenses | 191.02M | 0 | 18.24M | 53.34M | 51.53M | 51.87M | 62.24M | 262.02M |
| OpEx / Revenue % | 22.71% | 0% | 1.65% | 4.76% | 4.71% | 4.5% | 5.18% | 21.3% |
| Depreciation & Amortization | -613.67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Combined Ratio % | 22.71% | 26.63% | 57.3% | 37.94% | 17.96% | 26.19% | 26.95% | 30.2% |
| Operating Income | 613.67M▲ 0% | 718.17M▲ 17.0% | 472.42M▼ 34.2% | 695.22M▲ 47.2% | 898.22M▲ 29.2% | 851.51M▼ 5.2% | 878.06M▲ 3.1% | 858.84M▼ 2.2% |
| Operating Margin % | 72.96% | 73.37% | 42.7% | 62.06% | 82.04% | 73.81% | 73.05% | 69.8% |
| Operating Income Growth % | - | 17.03% | -34.22% | 47.16% | 29.2% | -5.2% | 3.12% | -2.19% |
| EBITDA | 0 | 718.17M | 490.66M | 746.23M | 949.92M | 903.38M | 929.22M | 908.79M |
| EBITDA Margin % | 0% | 73.37% | 44.35% | 66.62% | 86.76% | 78.3% | 77.31% | 73.86% |
| Interest Expense | 0 | 0 | 18.24M | 51.01M | 51.7M | 51.87M | 51.16M | 49.95M |
| Non-Operating Income | 227.43M | 0 | -18.24M | -51.01M | -51.7M | -51.87M | -51.16M | -49.95M |
| Pretax Income | 613.67M▲ 0% | 718.17M▲ 17.0% | 472.42M▼ 34.2% | 695.22M▲ 47.2% | 898.22M▲ 29.2% | 851.51M▼ 5.2% | 878.06M▲ 3.1% | 858.84M▼ 2.2% |
| Pretax Margin % | 72.96% | 73.37% | 42.7% | 62.06% | 82.04% | 73.81% | 73.05% | 69.8% |
| Income Tax | 129.81M | 155.83M | 102M | 148.53M | 194.06M | 186M | 189.99M | 184.59M |
| Effective Tax Rate % | 21.15% | 21.7% | 21.59% | 21.36% | 21.61% | 21.84% | 21.64% | 21.49% |
| Net Income | 483.86M▲ 0% | 677.63M▲ 40.0% | 370.42M▼ 45.3% | 546.68M▲ 47.6% | 704.16M▲ 28.8% | 665.51M▼ 5.5% | 688.07M▲ 3.4% | 674.24M▼ 2.0% |
| Net Margin % | 57.53% | 69.23% | 33.48% | 48.8% | 64.31% | 57.69% | 57.25% | 54.8% |
| Net Income Growth % | - | 40.05% | -45.34% | 47.58% | 28.8% | -5.49% | 3.39% | -2.01% |
| EPS (Diluted) | 2.97▲ 0% | 3.45▲ 16.2% | 2.27▼ 34.2% | 3.36▲ 48.0% | 4.31▲ 28.3% | 4.11▼ 4.6% | 4.37▲ 6.3% | 4.52▲ 3.4% |
| EPS Growth % | - | 16.16% | -34.2% | 48.02% | 28.27% | -4.64% | 6.33% | 3.43% |
| EPS (Basic) | 2.97 | 3.45 | 2.27 | 3.36 | 4.32 | 4.14 | 4.40 | 4.54 |
| Diluted Shares Outstanding | 162.84M | 162.84M | 162.84M | 162.88M | 163.29M | 161.85M | 157.55M | 149.32M |
Enact Holdings, Inc. (ACT) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 4.1B | 4.56B | 5.7B | 5.91B | 5.74B | 6.22B | 6.55B | 6.89B |
| Asset Growth % | - | 11.13% | 25.1% | 3.79% | -3.02% | 8.4% | 5.34% | 5.25% |
| Total Investment Assets | 3.7B | 3.76B | 5.05B | 5.29B | 4.89B | 5.29B | 5.63B | 6.05B |
| Long-Term Investments | 3.7B | 3.76B | 5.05B | 5.29B | 4.89B | 5.29B | 5.63B | 6.05B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 199.06M | 626.22M | 499.26M | 468.09M | 555.51M | 660.75M | 652.46M | 628.62M |
| Cash & Equivalents | 159.05M | 585.06M | 452.79M | 425.83M | 513.77M | 615.68M | 599.43M | 582.49M |
| Receivables | 40.01M | 41.16M | 46.46M | 42.27M | 41.74M | 45.07M | 53.03M | 46.13M |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PP&E (Net) | 0 | 22.6M | 0 | 15.5M | 13.6M | 11.3M | 8.8M | 0 |
| Other Assets | 80.38M | 86.7M | 106.86M | 88.84M | 124.76M | 143.57M | 167.12M | 194.31M |
| Total Liabilities | 825.07M | 727.97M | 1.82B | 1.81B | 1.63B | 1.59B | 1.55B | 1.54B |
| Total Debt | 0 | 46.8M | 775.51M | 775.82M | 771.26M | 768.68M | 760.32M | 744.48M |
| Net Debt | -159.05M | -538.26M | 322.72M | 349.99M | 257.48M | 153M | 160.89M | 161.99M |
| Long-Term Debt | 0 | 23.4M | 707.14M | 758.12M | 755.32M | 755.15M | 749.74M | 744.48M |
| Short-Term Debt | 0 | 0 | 51.46M | 0 | 3.44M | 3.8M | 3.88M | 0 |
| Total Current Liabilities | 421.79M | 383.46M | 358.4M | 246.32M | 206.16M | 153.13M | 118.56M | 91.64M |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 421.79M | 383.46M | 306.94M | 246.32M | 202.72M | 149.33M | 114.68M | 91.64M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 |
| Other Liabilities | 375.27M | 245.59M | 651.63M | 736.53M | 634.27M | 640.11M | 650.44M | 702.16M |
| Total Equity | 3.27B▲ 0% | 3.83B▲ 16.9% | 3.88B▲ 1.4% | 4.11B▲ 5.8% | 4.1B▼ 0.1% | 4.63B▲ 13.0% | 5B▲ 7.9% | 5.36B▲ 7.2% |
| Equity Growth % | - | 16.9% | 1.43% | 5.76% | -0.11% | 12.96% | 7.85% | 7.19% |
| Shareholders Equity | 3.27B | 3.83B | 3.88B | 4.11B | 4.1B | 4.63B | 5B | 5.36B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 942.41M | 1.37B | 1.3B | 1.65B | 2.1B | 2.55B | 3.13B | 3.68B |
| Common Stock | 0 | 0 | 0 | 1.63M | 1.63M | 1.59M | 1.52M | 1.42M |
| Accumulated OCI | -26.52M | 93.43M | 208.38M | 83.58M | -382.74M | -230.4M | -207.45M | -30.14M |
| Return on Equity (ROE) | 14.78% | 19.09% | 9.61% | 13.69% | 17.16% | 15.24% | 14.29% | 13.03% |
| Return on Assets (ROA) | 11.8% | 15.66% | 7.23% | 9.42% | 12.09% | 11.14% | 10.78% | 10.03% |
| Equity / Assets | 79.87% | 84.02% | 68.12% | 69.42% | 71.5% | 74.5% | 76.28% | 77.68% |
| Debt / Equity | - | 0.01x | 0.20x | 0.19x | 0.19x | 0.17x | 0.15x | 0.14x |
| Book Value per Share | 20.10 | 23.50 | 23.84 | 25.21 | 25.11 | 28.62 | 31.71 | 35.86 |
| Tangible BV per Share | 20.10 | 23.50 | 23.84 | 25.21 | 25.11 | 28.62 | 31.71 | 35.86 |
Enact Holdings, Inc. (ACT) cash flow — operating, investing & free cash flow history
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 511.12M | 500.02M | 704.35M | 572.12M | 560.51M | 632.04M | 686.26M | 724.52M |
| Operating CF Growth % | - | -2.17% | 40.86% | -18.77% | -2.03% | 12.76% | 8.58% | 5.57% |
| Operating CF / Revenue % | 60.77% | 51.08% | 63.66% | 51.07% | 51.19% | 54.78% | 57.1% | 58.89% |
| Net Income | 483.86M | 677.63M | 370.42M | 546.68M | 704.16M | 665.51M | 688.07M | 674.24M |
| Depreciation & Amortization | 0 | -2.9M | 0 | 3.33M | -749K | 0 | 0 | 0 |
| Stock-Based Compensation | 4.1M | 2.9M | 0 | 1.5M | 9.88M | 15.28M | 18.77M | 0 |
| Deferred Taxes | 0 | 56.73M | 11.13M | -1.42M | -2.3M | -1.83M | 4.46M | 0 |
| Other Non-Cash Items | 179.53M | -78.14M | 12.91M | 907K | 7.74M | 14.62M | 27.99M | 34.5M |
| Working Capital Changes | -152.28M | -156.2M | 309.89M | 21.13M | -158.22M | -61.54M | -53.03M | 15.77M |
| Cash from Investing | -498.18M | 175.99M | -1.14B | -398.78M | -220.25M | -229.4M | -320.51M | -226.38M |
| Capital Expenditures | 0 | -175.99M | 0 | -685.65M | 6.62M | 0 | 0 | 0 |
| Acquisitions | 0 | 510.25M | 0 | -27.3M | -6.52M | 0 | 0 | 0 |
| Purchase of Investments | -1.26B | -951.28M | -1.94B | -1.58B | -1.22B | -1.04B | -1.61B | -1.9B |
| Sale/Maturity of Investments | 760.65M | 617.02M | 805.55M | 1.21B | 1.01B | 819.58M | 1.31B | 1.68B |
| Other Investing | -498.18M | 175.99M | 0 | 685.65M | -6.62M | -13.93M | -21.1M | -8.32M |
| Cash from Financing | -50M | -250M | 300.3M | -200.29M | -252.31M | -300.73M | -382M | -515.08M |
| Dividends Paid | -50M | -250M | -437.35M | -200.29M | -250.78M | -212.96M | -111.72M | -120.83M |
| Share Repurchases | 0 | 0 | 0 | 0 | -1.53M | -87.76M | -243.97M | -382.4M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 0 | 0 | 1000K | 0 | 0 | 0 | -1000K | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | -18.46M | -11.85M |
| Net Change in Cash | -37.06M▲ 0% | 426.01M▲ 1249.5% | -132.26M▼ 131.0% | -26.97M▲ 79.6% | 87.95M▲ 426.1% | 101.91M▲ 15.9% | -16.25M▼ 115.9% | -16.94M▼ 4.2% |
| Exchange Rate Effect | 0 | 0 | 0 | -7K | 0 | 0 | 0 | 0 |
| Cash at Beginning | 196.11M | 159.05M | 585.06M | 452.79M | 425.83M | 513.77M | 615.68M | 599.43M |
| Cash at End | 159.05M | 585.06M | 452.79M | 425.83M | 513.77M | 615.68M | 599.43M | 582.49M |
| Free Cash Flow | 511.12M▲ 0% | 324.03M▼ 36.6% | 704.35M▲ 117.4% | -113.53M▼ 116.1% | 567.13M▲ 599.5% | 632.04M▲ 11.4% | 686.26M▲ 8.6% | 724.52M▲ 5.6% |
| FCF Growth % | - | -36.6% | 117.37% | -116.12% | 599.52% | 11.45% | 8.58% | 5.57% |
| FCF Margin % | 60.77% | 33.1% | 63.66% | -10.14% | 51.8% | 54.78% | 57.1% | 58.89% |
| FCF per Share | 3.14 | 1.99 | 4.33 | -0.7 | 3.47 | 3.91 | 4.36 | 4.85 |
Enact Holdings, Inc. (ACT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 22.71% | 26.63% | 57.3% | 37.94% | 17.96% | 26.19% | 26.95% | 30.2% |
| Medical Cost Ratio | 0% | 26.63% | 55.65% | 33.18% | 13.25% | 21.7% | 21.77% | 8.9% |
| Return on Equity (ROE) | 14.78% | 19.09% | 9.61% | 13.69% | 17.16% | 15.24% | 14.29% | 13.03% |
| Return on Assets (ROA) | 11.8% | 15.66% | 7.23% | 9.42% | 12.09% | 11.14% | 10.78% | 10.03% |
| Equity / Assets | 79.87% | 84.02% | 68.12% | 69.42% | 71.5% | 74.5% | 76.28% | 77.68% |
| Book Value / Share | 20.1 | 23.5 | 23.84 | 25.21 | 25.11 | 28.62 | 31.71 | 35.86 |
| Debt / Equity | - | 0.01x | 0.20x | 0.19x | 0.19x | 0.17x | 0.15x | 0.14x |
| Revenue Growth | - | 16.38% | 13.04% | 1.24% | -2.26% | 5.37% | 4.18% | 2.37% |
Enact Holdings, Inc. (ACT) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 5, 2026·SEC
Feb 3, 2026·SEC
Nov 5, 2025·SEC
Feb 27, 2026·SEC
Enact Holdings, Inc. (ACT) stock FAQ — growth, dividends, profitability & financials explained
Enact Holdings, Inc. (ACT) grew revenue by 2.4% over the past year. Growth has been modest.
Yes, Enact Holdings, Inc. (ACT) is profitable, generating $674.2M in net income for fiscal year 2025 (54.8% net margin).
Yes, Enact Holdings, Inc. (ACT) pays a dividend with a yield of 1.91%. This makes it attractive for income-focused investors.
Enact Holdings, Inc. (ACT) has a return on equity (ROE) of 13.0%. This is reasonable for most industries.
Enact Holdings, Inc. (ACT) has a combined ratio of 30.2%. A ratio below 100% indicates underwriting profitability.
Enact Holdings, Inc. (ACT) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates